Understanding the challenges within the ocular injection lifecycle
We heard first hand from an Ophthalmic Surgeon that the repetitive nature of ocular injections provides the largest challenge. The continual rise in treatment volumes, coupled with the absence of longer-acting therapies, places significant financial and operational strain on the NHS. [3]
The Support Service Manager guided us through their own journey of feeling underprepared and isolated. After such a distressing experience, they never returned for subsequent injections leading to further loss of vision.
Key challenges to the field were extracted from our conversation:
- Dull and bulky needles increasing risk of infection
- Lack of design feedback with implant devices leaving users uncertain if the implant has deployed
- Fear and lack of clear post treatment support
- Accessibility challenged travelling to and from appointments
